Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Objectives</h3><p>Delirium is the most common postoperative neurological complication and some evidence suggests that dexmedetomidine is associated with a decreased incidence of delirium. This study is designed to assess the effect of dexmedetomidine on postoperative delirium (POD) in elderly patients with mild cognitive impairment (MCI).</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>Sixty geriatric patients with MCI were enrolled and ramdomly divided into two groups by a computer‐generated randomisation sequence: dexmedetomidine group (D group) and normal saline group (C group). Patients in D group received a loading dose of 0.5 μg/kg dexmedetomidine over 10 minutes before anesthesia induction, followed by a continuous infusion of 0.4 μg·kg<sup>‐1</sup>·h<sup>‐1</sup> until 30 min before the end of surgery; equal volume of normal saline was given in C group. Blood samples were extracted to detect the concentration of cytokines, including TNF‐α, IL‐10, HO‐1, matrix metalloproteinase‐9 (MMP‐9) and glial fibrillary acidic protein (GFAP) before anesthesia induction (T<sub>1</sub>), before suture (T<sub>2</sub>), and 30 min after surgery (T<sub>3</sub>). Postoperative recovery times were recorded. Delirium was assessed with the 3‐Minute Diagnostic Interview for confusion assessment method during the first 7 days postoperatively. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>POD occurred in 10 (33.3%) of 30 patients in C group, and in 3 (10%) of 30 patients given dexmedetomidine (odds ratio [OR] 0.222, 95% CI 0.054–0.914; <i>P</i>=0.028). The serum concentrations of TNF‐α, MMP‐9, and GFAP were significantly increased and IL‐10 was decreased in the C group than in the D group at T<sub>2</sub> and T<sub>3</sub>. No differences were observed between groups in the level of HO‐1. Analysis using random‐effect multivariable logistic regression indicated that POD was associated with GFAP (odds ratio [OR] 16.691, 95% CI 2.288–121.746; <i>P</i>=0.005). The positive predictive ability of the multivariate logistic regression model tested by ROC analysis showed an area under the curve of 0.713 (95% CI, 0.584–0.842). </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusions</h3><p>Dexmedetomidine can alleviate POD in elderly patients with MCI and may be related to reduce the neuroinflammation by lowering the permeability of blood‐brain barrier.</p><p>This article is protected by copyright. All rights reserved.</p></section>

Dexmedetomidine nasal administration improves perioperative sleep quality and neurocognitive deficits in elderly patients undergoing general anesthesia

Intranasal dexmedetomidine improves postoperative sleep quality in older patients with chronic insomnia: a randomized double-blind controlled trial

Dexmedetomidine Might Improve Postoperative Cognitive Dysfunction in Older Patients Undergoing Pulmonary Surgery

Effect of Dexmedetomidine with Different Anesthetic Dosage on Neurocognitive Function in Elderly Patients After Operation Based on Neural Network Model

Low-dose Dexmedetomidine Improves Sleep Quality Pattern in Elderly Patients after Noncardiac Surgery in the Intensive Care Unit: A Pilot Randomized Controlled Trial.

Effect of dexmedetomidine on convalescence quality after general anesthesia and postoperative delirium, and on cognitive function in elderly patients undergoing lower limb surgery

Effect of dexmedetomidine on the Montreal Cognitive Assessment in older patients undergoing pulmonary surgery

Application value of dexmedetomidine in anesthesia for elderly patients undergoing radical colon cancer surgery

Effects of dexmedetomidine combined with etomidate on postoperative cognitive function in older patients undergoing total intravenous anaesthesia: a randomized, double-blind, controlled trial

The effect of dexmedetomidine on the incidence of postoperative delirium in critically ill elderly patients

Effects of dexmedetomidine at different dosages on perioperative haemodynamics and postoperative recovery quality in elderly patients undergoing hip replacement surgery under general anaesthesia: a randomized controlled trial

Effect of mini-dose dexmedetomidine supplemented intravenous analgesia on sleep structure in older patients after major noncardiac surgery: A randomized trial

Effect of Intraoperative Dexmedetomidine Dose on Postoperative First Night Sleep Quality in Elderly Surgery Patients: A Retrospective Study With Propensity Score-Matched Analysis

Clinical observation of dexmedetomidine nasal spray in the treatment of sleep disorders on the first night after undergoing maxillofacial surgery: a single-center double-blind randomized controlled study

The role of dexmedetomidine administered via intravenous infusion as adjunctive therapy to mitigate postoperative delirium and postoperative cognitive dysfunction in elderly patients undergoing regional anesthesia: a meta-analysis of randomized controlled trials

Dexmedetomidine in Combination with Morphine Improves Postoperative Analgesia and Sleep Quality in Elderly Patients after Open Abdominal Surgery: A Pilot Randomized Control Trial.

Benefits of Dexmedetomidine in Improving Postoperative Recovery

Advances in the use of dexmedetomidine during the perioperative period to improve postoperative sleep quality in patients undergoing surgery

Effects of short-term preoperative intranasal dexmedetomidine plus conventional treatment on delirium following cardiac surgery in patients with sleep disorders

Dexmedetomidine effect on delirium in elderly patients undergoing general anesthesia

Intraoperative dexmedetomidine for prevention of postoperative delirium in elderly patients with mild cognitive impairment